Replimune REPL
NASDAQ REPL
$23.28 +1.02 (+4.58%)
At close: Nov 10, 2026 · 4:00 PM EST

Replimune (REPL) Inventory (2026)

Updated

Replimune's Inventory was $9.87 million in fiscal Q2 2027 (quarter ended Sep 30, 2026).

Analysis

Replimune (REPL) Inventory (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 18.19 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 15.38 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 5.31 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 6.16 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 6.22 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 6.93 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 6.39 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 1.90 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 10.02 Bn
10 Replimune 2.40 Bn 1.35 Bn - 9.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.87 Mn
API Access

Replimune Inventory API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=inventory&ticker=REPL&period=max&api_key=YOUR_API_KEY